Literature DB >> 28217918

Editorial: Prevention of Rheumatoid Arthritis: Now Is the Time, but How to Proceed?

Kevin D Deane1, Christopher C Striebich1, V Michael Holers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28217918      PMCID： PMC5406258          DOI： 10.1002/art.40061

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  23 in total

1.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

2.  The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis.

Authors:  Klaus P Machold; Robert Landewé; Josef S Smolen; Tanja A Stamm; Désirée M van der Heijde; Kirsten N Verpoort; Kerstin Brickmann; Janitzia Vázquez-Mellado; Dimitri E Karateev; Ferdinand C Breedveld; Paul Emery; Thomas W J Huizinga
Journal:  Ann Rheum Dis       Date:  2010-03       Impact factor: 19.103

3.  Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study).

Authors:  Jill van Aken; Lotte Heimans; Henrike Gillet-van Dongen; Karen Visser; H Karel Ronday; Irene Speyer; André J Peeters; Tom W J Huizinga; Cornelia F Allaart
Journal:  Ann Rheum Dis       Date:  2013-01-19       Impact factor: 19.103

4.  Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.

Authors:  Henrike van Dongen; Jill van Aken; Leroy R Lard; Karen Visser; H Karel Ronday; Harry M J Hulsmans; Irene Speyer; Marie-Louise Westedt; André J Peeters; Cornelia F Allaart; René E M Toes; Ferdinand C Breedveld; Tom W J Huizinga
Journal:  Arthritis Rheum       Date:  2007-05

5.  Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial.

Authors:  S M M Verstappen; M J McCoy; C Roberts; N E Dale; A B Hassell; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2009-10-12       Impact factor: 19.103

Review 6.  Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.

Authors:  Kevin D Deane; Hani El-Gabalawy
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

7.  The end of the disease era.

Authors:  Mary E Tinetti; Terri Fried
Journal:  Am J Med       Date:  2004-02-01       Impact factor: 4.965

8.  Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial.

Authors:  W H Bos; B A C Dijkmans; M Boers; R J van de Stadt; D van Schaardenburg
Journal:  Ann Rheum Dis       Date:  2009-04-09       Impact factor: 19.103

9.  Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial).

Authors:  P Emery; P Durez; M Dougados; C W Legerton; J-C Becker; G Vratsanos; H K Genant; C Peterfy; P Mitra; S Overfield; K Qi; R Westhovens
Journal:  Ann Rheum Dis       Date:  2009-11-23       Impact factor: 19.103

10.  Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort.

Authors:  Iuliia Biliavska; Tanja A Stamm; Jose Martinez-Avila; Thomas W J Huizinga; Robert B M Landewé; Günter Steiner; Daniel Aletaha; Josef S Smolen; Klaus P Machold
Journal:  Ann Rheum Dis       Date:  2012-09-15       Impact factor: 19.103
View more
  9 in total

1.  Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis.

Authors:  Lindsay B Kelmenson; Brandie D Wagner; Bryan K McNair; Ashley Frazer-Abel; M Kristen Demoruelle; Dylan T Bergstedt; Marie L Feser; Laura K Moss; Mark C Parish; Elizabeth A Mewshaw; Ted R Mikuls; Jess D Edison; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheumatol       Date:  2019-12-26       Impact factor: 10.995

Review 2.  Individuals at risk of seropositive rheumatoid arthritis: the evolving story.

Authors:  S Rantapää Dahlqvist; F Andrade
Journal:  J Intern Med       Date:  2019-10-21       Impact factor: 8.989

3.  Development and validation of risk stratification trees for incident slow gait speed in persons at high risk for knee osteoarthritis.

Authors:  Leena Sharma; Kent Kwoh; Jungwha Julia Lee; Jane Cauley; Rebecca Jackson; Marc Hochberg; Alison H Chang; Charles Eaton; Michael Nevitt; Jing Song; Orit Almagor; Joan S Chmiel
Journal:  Ann Rheum Dis       Date:  2019-06-26       Impact factor: 19.103

4.  The Utilization of Autoantibodies in Approaches to Precision Health.

Authors:  Marvin J Fritzler; Laura Martinez-Prat; May Y Choi; Michael Mahler
Journal:  Front Immunol       Date:  2018-11-16       Impact factor: 7.561

Review 5.  Roles of mast cells in rheumatoid arthritis.

Authors:  Hong Ki Min; Kyoung-Woon Kim; Sang-Heon Lee; Hae-Rim Kim
Journal:  Korean J Intern Med       Date:  2019-11-15       Impact factor: 2.884

Review 6.  Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study.

Authors:  Lourdes M Perez-Chada; Rebecca H Haberman; Joseph F Merola; Jose U Scher; Vinod Chandran; Cheryl F Rosen; Christopher Ritchlin; Lihi Eder; Philip Mease; Soumya Reddy; Alexis Ogdie
Journal:  Nat Rev Rheumatol       Date:  2021-02-15       Impact factor: 20.543

7.  Post-GWAS functional studies reveal an RA-associated CD40-induced NF-kB signal transduction and transcriptional regulation network targeted by class II HDAC inhibitors.

Authors:  Meijuan Zou; Danli Jiang; Ting Wu; Xiaoyu Zhang; Yihan Zhao; Di Wu; Wei Sun; Jing Cui; Larry Moreland; Gang Li
Journal:  Hum Mol Genet       Date:  2021-05-28       Impact factor: 6.150

8.  Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting.

Authors:  Elizabeth A Bemis; M Kristen Demoruelle; Jennifer A Seifert; Kristen J Polinski; Michael H Weisman; Jane H Buckner; Peter K Gregersen; Ted R Mikuls; James R ODell; Richard M Keating; Kevin D Deane; V Michael Holers; Jill M Norris
Journal:  Ann Rheum Dis       Date:  2020-09-14       Impact factor: 27.973

9.  Berberine Delays Onset of Collagen-Induced Arthritis through T Cell Suppression.

Authors:  Alexandra A Vita; Hend Aljobaily; David O Lyons; Nicholas A Pullen
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.